P249 PROMOTER SQUELCHING AS A TOOL TO DOWNREGULATE THE INFLAMMATORY CASCADE IN CANINE OSTEOARTHRITIS  by Rachakonda, S. et al.
Osteoarthritis and Cartilage Vol. 14, Supplement B S135
UK (n = 352) and Greece (n = 157) were also studied. Controls
were selected to exclude clinical OA symptoms and were older
than 44 years (from Greece, n = 183), or of 54 years (from Spain,
n = 294, and the UK n = 454). Two ADAMTS5 non-synonymous
SNPs identified by the software SIFT as probably damaging the
enzyme function, rs226794 in exon 7 (P692L) and rs2830585 in
exon 5 (R614H), were studied.
Results: SNP R614H did not show allelic frequency differences
between controls and any of the three OA patient groups in the
Spanish sample collection and was not studied further. The minor
allele of SNP P692L, allele T, showed a trend to a decreased
frequency in Spanish TKR patients (11.5% vs 8.2% in controls,
p = 0.06). The Greek TKR samples did not show a significant
difference (9.8% in TKR vs 8.0% in controls), neither so the
UK TKR samples (10.9% in TKR vs 11.2% in controls). The
combined analysis did not show any effect of the P692L SNPs
(Mantel-Haenszel O.R. = 0.88, 95% C.I: 0.7-1.1, p = 0.25).
Conclusions: A first investigation of putative important SNPs in
the main in vivo aggrecanase, ADAMTS5, has failed to show any
relevant effect on OA susceptibility.
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Purpose: Osteoarthritis (OA) characterised by cartilage degra-
dation is a severe joint disorder affecting animals and humans
alike. Canine species provide a useful model to study this dis-
ease process as it mimics the human form of OA both clinically
and pathophysiologically. It has been proven that IL-1β and TNFα
are the inflammatory cytokines that accentuate the disease pro-
cess. The absence of Th2 cells in the inflammatory synovial fluid
points out that this disorder could be corrected by installing a
balance between the Th1 and Th2-response. Previous work has
shown that Interleukin 4 (IL-4) downregulates the inflammatory
pathway and therefore is a good candidate to combat OA in
canine species.
Methods: Present work focuses on simulating the OA disease
process in-vitro using canine chondrocytes in monolayer and 3D
cell culture systems. Our approach is based on dosage regulated
IL-4 expression under cell culture conditions. To achieve this we
are using promoter squelching as a method to self regulate
IL-4 expression involving the canine COX-2 promoter which we
partially sequenced.
Results: Our experiments have shown that canine chondrocytes
can be passaged till the 7th generation without any change in
morphology. We could also show by qPCR that these cells over
express inflammatory cytokines such as IL-6, IL-8 and IL-18 in
comparison to the house keeping gene GAPDH upon exogenous
stimulation with either human recombinant IL-1β or TNFα.
Conclusions: We report on the optimization of our canine in-
vitro model for OA therapy which includes IL-1β and TNFα
synthesis from canine PBMC as well as a reporter assay for
COX-2 promoter activity for our indigenously designed vector.
Efforts are on the way to increase expression levels of canine
IL-4 in cell culture.
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Purpose: Matrilin-3 is an extracellular matrix molecule showing
expression in growing skeletal tissues. Mutations in the matrilin-
3 gene (MATN3) are associated with mild forms of multiple
epiphyseal dysplasia and with hand osteoarthritis (hand OA).
Stefansson et al., 2003 identified a missense mutation (p.T303M)
in MATN3 (designated as SNP5) in a large cohort of patients from
Iceland which cosegregates with hand OA in several families. The
frequency of the mutant T allele is slightly more than 2% in the
Icelandic population and has a relative risk of 2.1. The aim of this
study was to replicate these recent findings in a German cohort
and to investigate a possible association with other forms of OA
Methods: We investigated 50 Caucasian patients with radio-
graphic and symptomatic hand OA of the first carpometacarpal
joint (CMC1), 176 Caucasian patients with radiographic and
symptomatic knee OA and 356 unrelated Caucasian control in-
dividuals from Germany. The genotyping of SNP5 and SNP6 in
the MATN3 gene (nomenclature as in Stefansson et al. 2003)
was performed by PCR amplification and subsequent cycle se-
quencing.
Results: Analysing the rare T allele of SNP5 we observed
expression in 10% of the hand OA patients (p = 0.00099) and
in 2.5% of healthy controls (p = 0.00670). The p-value remained
significant even after Bonferoni correction for multiple testing.
Thus, carriers of the T allele had an increased risk for developing
hand OA with an odds ratio of 4.28 (95% CI, 1.18-14.8). No
difference in allele frequency and no significant association could
be observed between this allele and the occurrence of knee OA
in our cohort (p = 0.85755). In contrast, the A allele of SNP6
did not show a significant difference in allele frequency in both
cohorts. The A allele was present in 30% of the hand OA patients
and in 40.5% of the control individuals, resulting in an odds ratio
of 0.63 (95% CI, 0.31-1.24), which exclude an association with
hand OA in our cohort. Also in the group of knee OA patients
there was no significant difference in the frequency of the A allele
as well as in the distribution of genotypes.
Conclusions: Our results support the importance of SNP5 for
this specific form of OA, but not for knee OA where no asso-
ciation could be found. These data are in accordance with the
published data from Stefansson et al., 2003 but in contrast to
the observation of Min et al., 2006. which could not verify the T
allele of SNP5 for an association with hand OA. This may be due
to variant diagnostic criteria or to the allele frequency difference
in the control group. However, further studies on the phenotype
correlation would help to clarify the role of matrilin-3 in cartilage
organisation.
